Induction in vitro of reversible immunosuppression and inhibition of B cell receptor regeneration by defined metabolites of cyclophosphamide.
D000171:Acrolein / Q000494:pharmacology; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D003520:Cyclophosphamide / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006462:Hemolytic Plaque Technique; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D008297:Male; D008558:Melphalan / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D011947:Receptors, Antigen, B-Cell / Q000096:biosynthesis*; D013154:Spleen / Q000276:immunology
D011947:Receptors, Antigen, B-Cell; D000171:Acrolein; D003520:Cyclophosphamide; D008558:Melphalan